眼表鞘脂与春季角结膜炎难治性相关:VKC发病机制新见解
该前瞻性研究纳入活动期春季角结膜炎(VKC)87例和年龄匹配健康对照60例,通过结膜印迹细胞学检测鞘脂代谢酶基因表达、泪液LC-MS/MS检测鞘脂水平,发现重症/极重症VKC泪液鞘氨醇-1-磷酸和神经酰胺水平降低,提示眼表鞘脂代谢改变与VKC难治性相关。
要点
- 重症/极重症VKC泪液S1P(d17:0)、S1P(d20:1)较轻度/中度和对照显著降低。
- 重症/极重症VKC泪液Cer(d18:/17:0)、C1P(d18:1/8:0)较轻度/中度降低。
- IgE刺激肥大细胞后S1P1和S1P3受体基因及组蛋白去乙酰化酶1、6蛋白表达增加。
核心结论
- 眼表鞘脂代谢改变导致重症/极重症VKC泪液神经酰胺和鞘氨醇水平低于轻度/中度病例,为难治性VKC干预提供新靶点。
研究设计与样本
- 2年前瞻性研究在南印度三级眼科中心招募活动期VKC病例87例(按症状分为轻度/中度和重度/极重度)及年龄匹配健康对照60例。
- 采用结膜印迹细胞学评估鞘脂代谢酶基因表达,泪液LC-MS/MS检测鞘脂水平,并进行体外肥大细胞实验评估IgE诱导的S1P受体表达和组蛋白修饰改变。
主要发现
- VKC病例结膜印迹细胞中鞘脂代谢酶和S1P受体(S1P3R)基因表达显著改变。
- 混合泪液分析显示重症/极重症VKC中S1P(d17:0)、S1P(d20:1)(p<0.001)和S1P(d17:1)(p<0.01)较轻度/中度VKC和对照显著降低。
- 重症/极重症VKC中Cer(d18:/17:0)(p<0.001)、C1P(d18:1/8:0)(p<0.01)和C1P(d18:1/2.0(p<0.05)较轻度/中度VKC降低。
- IgE处理的培养肥大细胞显示S1P1和S1P3受体基因表达及组蛋白去乙酰化酶(1、6)蛋白表达显著增加。
临床怎么用
- 泪液鞘脂谱(尤其是S1P和神经酰胺水平)可能有助于识别难治性重症VKC病例。
- 鞘脂代谢通路和S1P受体可能成为难治性VKC的干预靶点。
局限性
- 原文未明确报告研究局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The etiopathogenesis of vernal keratoconjunctivitis (VKC) is incompletely understood. Bioactive lipids play a key role in allergic disorders. This study focused on the sphingolipid metabolism on the ocular surface of VKC and to explore if it has a contributory role in the refractoriness of the disease. METHODS: Active VKC cases, (n=87) (classified as mild/moderate and severe/very severe based on the disease symptoms) and age-matched healthy controls (n=60) were recruited as part of a 2-year prospective study at a tertiary eye care centre in South India. Conjunctival imprint cytology was used to assess gene expression of enzymes of sphingolipids metabolism. Sphingolipids were estimated in the tears by LC-MS/MS analysis. In vitro study was done to assess IgE-induced alterations in sphingosine-1-phosphate (S1P) receptor expression and histone modification in cultured mast cells. RESULTS: Significantly altered gene expression of the sphingolipids enzymes and S1P receptor (SIP3R) were observed in conjunctival imprint cells of VKC cases. Pooled tears analysis revealed significantly lowered levels of S1P(d17:0), S1P(d20:1) (p<0.001) and S1P(d17:1) (p<0.01) specifically in severe/very severe VKC compared with both mild/moderate VKC and control. Cer(d18:/17:0) (p<0.001), ceramide-1-phosphate (C1P)(d18:1/8:0) (p<0.01) and C1P(d18:1/2.0 (p<0.05) were lowered in severe/very severe VKC compared with mild/moderate VKC. Cultured mast cells treated with IgE revealed significantly increased gene expression of S1P1 and 3 receptors and the protein expression of histone deacetylases (1, 6). CONCLUSION: Altered sphingolipid metabolism in the ocular surface results in low tear ceramide and sphingosine levels in severe/very severe VKC compared with the mild/moderate cases. The novel finding opens up fresh targets for intervention in these refractory cases.
引用
- Menta V, Agarwal S, Das US, et al. Ocular surface sphingolipids associate with the refractory nature of vernal keratoconjunctivitis: newer insights in VKC pathogenesis. Br J Ophthalmol. 2021. PMID: 34670752. doi:10.1136/bjophthalmol-2021-319324
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。